Fraser Charles D, Morchi Raveendra, Stone Matthew L, Jaggers James, Campbell David, Mitchell Max B
Section of Pediatric Cardiac Surgery, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colo.
JTCVS Tech. 2024 Sep 10;28:132-138. doi: 10.1016/j.xjtc.2024.08.022. eCollection 2024 Dec.
Prior studies suggest that prolonged donor heart warm ischemia time increases heart transplant mortality. Patients with single-ventricle heart disease requiring transplant with concomitant aortic arch or central pulmonary artery reconstruction present technical challenges that extend donor warm ischemia time using conventional techniques. Studies in larger pediatric and adult patients with single-ventricle anatomy have described the use of prosthetic material for concomitant great vessel reconstruction. We have used donor free arterial grafts to simplify concomitant great vessel reconstructions and reduce warm donor ischemia time in small patients with single-ventricle physiology undergoing heart transplant. The purpose of this study is to review our results in these patients.
Children with single-ventricle heart disease who underwent free donor arterial graft great vessel reconstruction at heart transplant were identified, divided into aortic arch and central pulmonary artery groups, and retrospectively reviewed. Warm and total ischemia times were recorded contemporaneously at transplant.
Fifteen pediatric patients with single-ventricle physiology underwent donor free arterial graft great vessel reconstructions (9 aortic arch, 6 pulmonary artery). Mean donor warm and total ischemia times for the entire cohort were 52.8 ± 10.7 and 341.7 ± 41.2 minutes. Two patients required postoperative extracorporeal membrane oxygenation. Hospital survival was 94% (1 death). There were no late deaths, and 2 patients had late retransplant. There were no early or late aortic or pulmonary artery obstructions, reinterventions, or complications at median follow-up of 14.2 years (interquartile range, 4.2-16.3 years).
Donor free arterial grafts for concomitant great vessel reconstruction during heart transplant in small, single-ventricle patients reduces warm ischemia time, simplifies technical demands, and preserves growth potential.
先前的研究表明,供体心脏热缺血时间延长会增加心脏移植死亡率。患有单心室心脏病且需要进行移植并伴有主动脉弓或中央肺动脉重建的患者存在技术挑战,使用传统技术会延长供体热缺血时间。对患有单心室解剖结构的较大儿童和成人患者的研究描述了使用人工材料进行伴行大血管重建。我们使用供体游离动脉移植物来简化伴行大血管重建,并减少接受心脏移植的单心室生理小患者的供体热缺血时间。本研究的目的是回顾我们在这些患者中的结果。
确定在心脏移植时接受供体游离动脉移植物大血管重建的单心室心脏病患儿,分为主动脉弓组和中央肺动脉组,并进行回顾性分析。在移植时同步记录热缺血时间和总缺血时间。
15名单心室生理的儿科患者接受了供体游离动脉移植物大血管重建(9例为主动脉弓,6例为肺动脉)。整个队列的平均供体热缺血时间和总缺血时间分别为52.8±10.7分钟和341.7±41.2分钟。2例患者术后需要体外膜肺氧合。住院生存率为94%(1例死亡)。无晚期死亡,2例患者进行了晚期再次移植。在中位随访14.2年(四分位间距,4.2 - 16.3年)时,无早期或晚期主动脉或肺动脉梗阻、再次干预或并发症。
在小型单心室患者心脏移植期间,使用供体游离动脉移植物进行伴行大血管重建可减少热缺血时间,简化技术要求,并保留生长潜力。